THERMO FISHER SCIENTIFIC INC. Quarterly Deferred Income Tax Liabilities, Net in USD from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Thermo Fisher Scientific Inc. quarterly Deferred Income Tax Liabilities, Net history and growth rate from Q4 2015 to Q3 2024.
  • Thermo Fisher Scientific Inc. Deferred Income Tax Liabilities, Net for the quarter ending September 28, 2024 was $1.12B, a 57.1% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $1.12B -$1.5B -57.1% Sep 28, 2024 10-Q 2024-11-01
Q2 2024 $1.52B -$1.33B -46.7% Jun 29, 2024 10-Q 2024-08-02
Q1 2024 $1.81B -$1.17B -39.1% Mar 30, 2024 10-Q 2024-05-03
Q4 2023 $1.92B -$927M -32.5% Dec 31, 2023 10-Q 2024-11-01
Q3 2023 $2.62B -$520M -16.6% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $2.84B -$485M -14.6% Jul 1, 2023 10-Q 2023-08-04
Q1 2023 $2.98B -$517M -14.8% Apr 1, 2023 10-Q 2023-05-05
Q4 2022 $2.85B -$988M -25.7% Dec 31, 2022 10-K 2024-02-22
Q3 2022 $3.14B +$1.68B +114% Oct 1, 2022 10-Q 2022-11-04
Q2 2022 $3.33B +$1.7B +104% Jul 2, 2022 10-Q 2022-08-05
Q1 2022 $3.49B +$1.61B +85.3% Apr 2, 2022 10-Q 2022-05-06
Q4 2021 $3.84B +$2.04B +114% Dec 31, 2021 10-K 2023-02-23
Q3 2021 $1.47B -$63M -4.12% Oct 2, 2021 10-Q 2021-11-04
Q2 2021 $1.63B -$118M -6.74% Jul 3, 2021 10-Q 2021-08-06
Q1 2021 $1.89B -$252M -11.8% Apr 3, 2021 10-Q 2021-05-07
Q4 2020 $1.79B -$398M -18.2% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $1.53B -$473M -23.6% Sep 26, 2020 10-Q 2020-10-30
Q2 2020 $1.75B -$186M -9.61% Jun 27, 2020 10-Q 2020-07-31
Q1 2020 $2.14B -$8M -0.37% Mar 28, 2020 10-Q 2020-05-01
Q4 2019 $2.19B -$73M -3.22% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $2B -$549M -21.5% Sep 28, 2019 10-Q 2019-11-01
Q2 2019 $1.94B -$663M -25.5% Jun 29, 2019 10-Q 2019-08-02
Q1 2019 $2.15B -$461M -17.7% Mar 30, 2019 10-Q 2019-05-03
Q4 2018 $2.27B -$501M -18.1% Dec 31, 2018 10-K 2020-02-26
Q3 2018 $2.55B -$585M -18.7% Sep 29, 2018 10-Q 2018-11-02
Q2 2018 $2.6B +$279M +12% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $2.61B +$143M +5.79% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 $2.77B +$209M +8.17% Dec 31, 2017 10-K 2020-02-26
Q3 2017 $3.13B +$420M +15.5% Sep 30, 2017 10-Q 2017-11-03
Q2 2017 $2.32B -$161M -6.49% Jul 1, 2017 10-Q 2017-08-04
Q1 2017 $2.46B Apr 1, 2017 10-Q 2017-05-05
Q4 2016 $2.56B -$65.6M -2.5% Dec 31, 2016 10-K 2018-02-28
Q3 2016 $2.72B Oct 1, 2016 10-Q 2016-11-04
Q2 2016 $2.48B Jul 2, 2016 10-Q 2016-08-05
Q4 2015 $2.62B Dec 31, 2015 8-K 2017-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.